N. Biserna

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.

S. Rives, A. Baruchel, I. Baumann, 2021, Blood advances.

Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

J. Fangusaro, D. Hargrave, M. Massimino, 2021, Frontiers in Oncology.

Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia

T. Alonzo, P. Brown, J. Levine, 2021, Pediatric blood & cancer.